Chemoinformaics analysis of 1,7-Dihydroxy-3,5,6-trimethoxyxanthen-9-one
Molecular Weight | 318.281 | nRot | 3 |
Heavy Atom Molecular Weight | 304.169 | nRig | 17 |
Exact Molecular Weight | 318.074 | nRing | 3 |
Solubility: LogS | -3.584 | nHRing | 1 |
Solubility: LogP | 2.773 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
nHA | 7 | APOL | 41.6691 |
nHD | 2 | BPOL | 21.8569 |
QED | 0.715 |
Synth | 2.532 |
Natural Product Likeliness | 1.441 |
NR-PPAR-gamma | 0.925 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.692 |
Pgp-sub | 0.002 |
HIA | 0.044 |
CACO-2 | -4.944 |
MDCK | 0.000026 |
BBB | 0.011 |
PPB | 0.837519 |
VDSS | 0.924 |
FU | 0.213128 |
CYP1A2-inh | 0.926 |
CYP1A2-sub | 0.969 |
CYP2c19-inh | 0.163 |
CYP2c19-sub | 0.344 |
CYP2c9-inh | 0.479 |
CYP2c9-sub | 0.896 |
CYP2d6-inh | 0.36 |
CYP2d6-sub | 0.614 |
CYP3a4-inh | 0.395 |
CYP3a4-sub | 0.19 |
CL | 5.638 |
T12 | 0.672 |
hERG | 0.025 |
Ames | 0.603 |
ROA | 0.411 |
SkinSen | 0.797 |
Carcinogencity | 0.027 |
EI | 0.852 |
Respiratory | 0.371 |
NR-Aromatase | 0.843 |
Antiviral | Yes |
Prediction | 0.828355 |